Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL4173075 |
---|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
endothelial PAS domain protein 1/Endothelial PAS domain-containing protein 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1744522] [GtoPdb: 3148] [UniProtKB: Q99814] | ||||||||
GtoPdb | Binding affinity for the PAS-B domain of hHIF1α determined by ITC | - | 7.3 | pKd | 50 | nM | Kd | Cancer Res (2016) 76: 5491-500 [PMID:27635045] |
ChEMBL | Binding affinity to His-tagged HIF-2alpha PAS-B domain (unknown origin) after 2 hrs by scintillation proximity assay | B | 7.92 | pIC50 | 12 | nM | IC50 | J Med Chem (2018) 61: 9691-9721 [PMID:30289716] |
ChEMBL | Inhibition of N-(3-Chlorophenyl-4,6-t2)-4-nitrobenzo[c][1,2,5]oxadiazol-5-amine binding to his-tagged HIF-2alpha PAS-B domain (unknown origin) measured after 1 hr by scintillation proximity assay | B | 7.92 | pIC50 | 12 | nM | IC50 | J Med Chem (2019) 62: 6876-6893 [PMID:31282155] |
ChEMBL | Antagonist activity at HIF-2alpha in human 786-O cells assessed as free plasma adjusted EC50 for reduction in VEGFA concentration after 24 hrs by ELISA | B | 6.8 | pEC50 | 158 | nM | EC50 | J Med Chem (2018) 61: 9691-9721 [PMID:30289716] |
ChEMBL | Inhibition of HIF-2alpha (unknown origin) expressed in human 786-O cells assessed as reduction in VEGFA level incubated for 20 hrs prior to compound compound washout followed by supplementation of growth medium and subsequent compound addition and measured after 24 hrs by ELISA | B | 7.34 | pEC50 | 46 | nM | EC50 | J Med Chem (2019) 62: 6876-6893 [PMID:31282155] |
ChEMBL | Antagonist activity at HIF-2alpha in human 786-O cells assessed as reduction in VEGFA concentration after 24 hrs by ELISA | B | 7.39 | pEC50 | 41 | nM | EC50 | J Med Chem (2018) 61: 9691-9721 [PMID:30289716] |
ChEMBL | Antagonist activity at HIF-2alpha in human 786-O cells co-expressing HIF responsive element after 24 hrs by ONE-Glo luciferase reporter gene assay | B | 7.57 | pEC50 | 27 | nM | EC50 | J Med Chem (2018) 61: 9691-9721 [PMID:30289716] |
ChEMBL | Inhibition of HIF-2alpha (unknown origin) expressed in human 786-O cells measured after 24 hrs by one-glo luciferase reporter gene assay | B | 7.57 | pEC50 | 27 | nM | EC50 | J Med Chem (2019) 62: 6876-6893 [PMID:31282155] |
ChEMBL data shown on this page come from version 34:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]